MedGenome, Bengaluru-based genomics-driven diagnostics and research services company, has acquired a stake in GenX Diagnostics, a leading diagnostic lab chain in Odisha.

Founded in 2017, GenX Diagnostics has established a robust regional presence in Odisha, with seven diagnostic centres and 60 collection centres across the state, including a flagship laboratory in Saheed Nagar, Bhubaneshwar, accredited by both NABL and NABH.

MedGenome’s, state-of-the-art advanced science and technological capabilities, combined with GenX’s diagnostics leadership in the East, will empower the clinicians in Odisha with actionable insights from genetic data and enable them to prescribe targeted treatment for patients, improving healthcare outcomes.

Commenting on the acquisition, Dr Vedam Ramprasad, PhD, CEO, MedGenome, said, "This acquisition further aims to expand our network in Tier 2 and Tier 3 cities in India by driving deeper penetration, new market development, and bringing new tests to the market. With a focus on positioning Indian genomics globally, we develop solutions that cater to diverse markets worldwide.”

"This strategic collaboration aims to enhance healthcare services in the region, providing comprehensive and cutting-edge diagnostic solutions. We are committed to bringing sophisticated and advanced healthcare solutions to the people of Odisha. By combining our extensive product portfolio with MedGenome’s omics solutions, we will empower clinicians and consumers in Eastern India with the best diagnostic tools available,” said Dr Biswajit Mohanty, GenX Diagnostics, Bhubaneswar.